METTL16 inhibits papillary thyroid cancer tumorigenicity through m6A/YTHDC2/SCD1-regulated lipid metabolism
Authors:
Open Access
- 9 February 2024
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 81 (1) , 1-17
Abstract
Papillary thyroid carcinoma (PTC) stands as the leading cancer type among endocrine malignancies, and there exists a strong correlation between thyroid cancer and obesity. However, the clinical significance and molecular mechanism of lipid metabolism in the development of PTC remain unclear. In this study, it was demonstrated that the downregulation of METTL16 enhanced lipid metabolism and promoted the malignant progression of PTC. METTL16 was expressed at lower levels in PTC tissues because of DNMT1-mediated hypermethylation of its promoter. Loss- and gain-of-function studies clarified the effects of METTL16 on PTC progression. METTL16 overexpression increased the abundance of m6A in SCD1 cells, increasing RNA decay via the m6A reader YTHDC2. The SCD1 inhibitor A939572 inhibited growth and slowed down lipid metabolism in PTC cells. These results confirm the crucial role of METTL16 in restraining PTC progression through SCD1-activated lipid metabolism in cooperation with YTHDC2. This suggests that the combination of METTL16 and anti-SCD1 blockade might constitute an effective therapy for PTC.Keywords
Funding Information
- National Natural Science Foundation of China (32272952)
- Guangxi Science Foundation for Distinguished Young Scholars (2020GXNSFFA297008)
- Auhui Provincial Natural Science Foundation (2108085MH284)
- the Natural Science Research Project of Anhui Educational Committee (KJ2020A0580, KJ2021A0748)
This publication has 37 references indexed in Scilit:
- Surgical approach to level VI in papillary thyroid carcinoma: an overviewUpdates in Surgery, 2017
- Understanding the Intersections between Metabolism and Cancer BiologyCell, 2017
- Thyroid cancerThe Lancet, 2016
- HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing EventsCell, 2015
- Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic TargetThe Journal of Clinical Endocrinology & Metabolism, 2015
- The dynamic epitranscriptome: N6-methyladenosine and gene expression controlNature Reviews Molecular Cell Biology, 2014
- A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylationNature Chemical Biology, 2013
- Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop CodonsCell, 2012
- Human HMGCS2 Regulates Mitochondrial Fatty Acid Oxidation and FGF21 Expression in HepG2 Cell LineJournal of Biological Chemistry, 2011
- Transcriptional regulation of the human DNA Methyltransferase (dnmt1) geneGene, 2000